BREEZULA COVID UPDATE: Filing for Special Protocol Assessment with FDA
    Research/Science 5/30/2020

    At a glance
    In this educational post, the primary subjects mentioned are
    💧 Clascoterone (Breezula) (topical) 7.5%
    💊 Finasteride (oral)
    💧 Minoxidil (topical)
    💧 Ketoconazole (topical) 2x/week
    the tone is 😐 neutral with as effective as oral finasteride at 12 months results.

    Other terms

    The conversation discusses the progress of Clascoterone (Breezula) for hair loss treatment, noting that COVID-19 delayed female trials by three months but Phase III trials for males are proceeding with a Special Protocol Assessment filed with the FDA. Users express hope for Breezula as an alternative to existing treatments like finasteride and minoxidil, despite concerns about its potential high cost.
    View this post in the Community →

    Similar Community Posts Join

    5 / 97 results

    Related Research

    6 / 56 results